Sectors
TNGX
Tango Therapeutics, Inc.
27.23
1 x 26.94
1 x 27.24
bid
ask
-
0.44
1.59%
09:41 AM
timesize
| Ytd | 207.34% | |
| 1y | 324.80% |
26.99
day range
27.53
6.25
52 week range
34.39
| Open | 27.05 | Prev Close | 27.67 | Low | 26.99 | High | 27.53 | Mkt Cap | 3.36B |
| Vol | 87.00K | Avg Vol | 3.98M | EPS | -0.83 | P/E | -32.52 | Forward P/E | -17.81 |
| Beta | 1.16 | Short Ratio | 9.28 | Inst. Own | 119.67% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 28.32 | 200-d Avg | 18.04 | 1yr Est | 44.33 |
| Income Statement | |||
| Operating Expenses | 48.77M | ||
| Research and Development Expense | 33.53M | ||
| Selling, General and Administrative Expense | 15.24M | ||
| Operating Income | -48.77M | ||
| Income Tax Expense | 1000 | ||
| Net Income | -45.51M | ||
| Net Income Common Stock | -45.51M | ||
| Net Income Common Stock (USD) | -45.51M | ||
| Consolidated Income | -45.51M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -45.51M | ||
| Earning Before Interest & Taxes (USD) | -45.51M | ||
| Weighted Average Shares | 143.58M | ||
| Weighted Average Shares Diluted | 143.58M | ||
| Balance Sheet | |||
| Cash and Equivalents | 157.83M | ||
| Cash and Equivalents (USD) | 157.83M | ||
| Investments | 224.15M | ||
| Investments Current | 222.01M | ||
| Investments Non-Current | 2.14M | ||
| Current Assets | 392.33M | ||
| Property, Plant & Equipment Net | 41.03M | ||
| Total Assets | 435.79M | ||
| Debt Current | 2.83M | ||
| Total Debt | 32.79M | ||
| Current Liabilities | 14.33M | ||
| Debt Non-Current | 29.96M | ||
| Total Liabilities | 44.29M | ||
| Accumulated Retained Earnings (Deficit) | -648.67M | ||
| Accumulated Other Comprehensive Income | -115.00K | ||
| Shareholders Equity | 391.51M | ||
| Shareholders Equity (USD) | 391.51M | ||
| Assets Non-Current | 43.47M | ||
| Total Debt (USD) | 32.79M | ||
| Liabilities Non-Current | 29.96M | ||
| Trade and Non-Trade Payables | 2.43M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.44M | ||
| Net Cash Flow from Financing | 79.85M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 45.12M | ||
| Capital Expenditure | 2.00K | ||
| Issuance (Purchase) of Equity Shares | 80.38M | ||
| Net Cash Flow from Investing | 9.64M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 9.63M | ||
| Net Cash Flow from Operations | -44.36M | ||
| Share Based Compensation | 10.80M | ||